Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-31

Clinical Trial Update: Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis [Phase 4]

View source ↗

Summary

Phase IV trial evaluating efficacy and safety of MASI BONE S (Alendronate Sodium Trihydrate) in postmenopausal women with osteoporosis is ongoing; current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MASI BONE S (Alendronate Sodium Trihydrate)

Snippet

Sponsor: Yonsei University | Conditions: Osteoporosis | Phase 4 | Status: UNKNOWN